BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19222375)

  • 1. Analytical precision of the Urolizer for the determination of the BONN-Risk-Index (BRI) for calcium oxalate urolithiasis and evaluation of the influence of 24-h urine storage at moderate temperatures on BRI.
    Berg W; Bechler R; Laube N
    Clin Chem Lab Med; 2009; 47(4):478-82. PubMed ID: 19222375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of the BONN Risk Index for metabolic monitoring of patients with calcium oxalate urolithiasis: a clinical application study of the Urolizer.
    Berg W; Bechler R; Haas C; Laube N
    Urol Res; 2009 Apr; 37(2):55-62. PubMed ID: 19205684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of freezer storage of urine samples on the BONN-Risk-Index for calcium oxalate crystallization.
    Laube N; Zimmermann DJ
    Clin Chem Lab Med; 2004; 42(6):665-9. PubMed ID: 15259384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.
    Porowski T; Zoch-Zwierz W; Konstantynowicz J; Taranta-Janusz K
    Pediatr Nephrol; 2008 Jul; 23(7):1123-8. PubMed ID: 18335253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bonn Risk Index based micromethod for assessing risk of urinary calcium oxalate stone formation.
    Porowski T; Mrozek P; Sidun J; Zoch-Zwierz W; Konstantynowicz J; Kirejczyk JK; Motkowski R; Laube N
    J Urol; 2010 Mar; 183(3):1157-62. PubMed ID: 20096860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions?
    Laube N; Hergarten S
    J Urol; 2005 Jun; 173(6):2175-7. PubMed ID: 15879882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine.
    Laube N; Schneider A; Hesse A
    Urol Res; 2000 Aug; 28(4):274-80. PubMed ID: 11011968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Problems in the investigation of urine from patients suffering from primary hyperoxaluria type 1.
    Laube N; Hoppe B; Hesse A
    Urol Res; 2005 Nov; 33(5):394-7. PubMed ID: 16151774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium oxalate urolithiasis in children: urinary promoters/inhibitors and role of their ratios.
    Turudic D; Batinic D; Golubic AT; Lovric M; Milosevic D
    Eur J Pediatr; 2016 Dec; 175(12):1959-1965. PubMed ID: 27730307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
    Kavanagh JP; Laube N
    J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical validation of urinary indole-reacted calcium oxalate crystallization index (iCOCI) test for diagnosing calcium oxalate urolithiasis.
    More-Krong P; Tubsaeng P; Madared N; Srisa-Art M; Insin N; Leeladee P; Boonla C
    Sci Rep; 2020 May; 10(1):8334. PubMed ID: 32433482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alteration of urine composition due to stone material present in the urinary tract.
    Laube N; Pullmann M; Hergarten S; Schmidt M; Hesse A
    Eur Urol; 2003 Nov; 44(5):595-9. PubMed ID: 14572760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correspondence between Ca²⁺ and calciuria, citrate level and pH of urine in pediatric urolithiasis.
    Porowski T; Kirejczyk JK; Konstantynowicz J; Kazberuk A; Plonski G; Wasilewska A; Laube N
    Pediatr Nephrol; 2013 Jul; 28(7):1079-84. PubMed ID: 23377289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic and physico-chemical urolithiasis parameters in the first morning urine.
    Serić V; Dutour-Sikirić M; Mihaljević I; Tucak-Zorić S; Bilić-Curcić I; Babić-Ivancić V
    Coll Antropol; 2009 Dec; 33 Suppl 2():85-92. PubMed ID: 20120404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collection and storage of urine specimens for measurement of urolithiasis risk factors.
    Wu W; Yang D; Tiselius HG; Ou L; Mai Z; Chen K; Zhu H; Xu S; Zhao Z; Zeng G
    Urology; 2015 Feb; 85(2):299-303. PubMed ID: 25623670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children.
    Porowski T; Zoch-Zwierz W; Wasilewska A; Spotyk A; Konstantynowicz J
    Pediatr Nephrol; 2007 Apr; 22(4):514-20. PubMed ID: 17216257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of calcium oxalate crystal formation in urine.
    Laube N; Klein F; Bernsmann F
    Urolithiasis; 2017 Apr; 45(2):151-157. PubMed ID: 27328814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].
    Laube N; Schmidt M; Hesse A
    Urologe A; 2003 Feb; 42(2):243-9. PubMed ID: 12607094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New diagnostic tool for individual monitoring of urolithiasis risk and other metabolic diseases].
    Laube N; Klein F; Bernsmann F; Fisang C
    Dtsch Med Wochenschr; 2014 Aug; 139(34-35):1721-5. PubMed ID: 25116022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.